Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$79.29

0.56 (0.71%)

07:14
04/13/18
04/13
07:14
04/13/18
07:14

Eli Lilly upgraded to Market Perform at BMO Capital on valuation

As reported earlier, BMO Capital analyst Alex Arfaei upgraded Eli Lilly to Market Perform from Underperform and raised his price target to $79 from $74. The analyst believes that his previously expressed concerns around the downside risks for Humalog, cautious outlook for Vernezio, and uncertainty around Bari are "mostly reflected" in the stock, with more balance in risk-reward going forward. While he anticipates 2018 to be volatile as maturing diabetes franchise constrains the company's growth plans, Arfaei also sees some tailwinds for Eli Lilly around continued strong growth of Trulicity, further growth of Taltz, Jardiance, and Basglar, as well as potential divestiture of Elanco.

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 07

    May

  • 21

    May

  • 07

    Jun

LLY Eli Lilly
$79.29

0.56 (0.71%)

03/27/18
03/27/18
UPGRADE
Target $8

Buy
Aratana Therapeutics upgraded on Entyce traction, M&A potential at Stifel
As previously reported, Stifel analyst Jonathan Block upgraded Aratana Therapeutics (PETX) to Buy from Hold. The early traction for Entyce, which was launched October 2017, has increased his conviction that the drug will act as the main revenue driver for Aratana in coming years, Block tells investors. Additionally, he argues that Aratana's portfolio may be appealing to a big animal health company, with Lilly's (LLY) Elanco viewed by Block as the most obvious candidate. The analyst raised his price target on Aratana shares to $8 from $6.
04/05/18
RHCO
04/05/18
NO CHANGE
Target $101
RHCO
Buy
Eli Lilly supported by positive oncology and diabetes findings, says SunTrust
SunTrust analyst John Boris keeps his Buy rating and $101 price target on Eli Lilly (LLY), citing the latest developments in Oncology and Diabetes. In Oncology, Boris points to the positive Overall Survival and Progression Free Survival data for Cyramza in second-line hepatocellular carcinoma, though he sees the commercial opportunity in Hepatocellular Carcinoma as limited. In Diabetes, the analyst points to the latest data showing Trulicity gaining market share on Novo Nordisk's (NVO) Victoza in the GLP-1 market.
04/12/18
SBSH
04/12/18
NO CHANGE
SBSH
Sell
Pfizer has no interest in acquiring Bristol-Myers right now, says Citi
Citi analyst Andrew Baum says Pfizer's (PFE) CEO made it clear to him that the company has no interest in acquiring Bristol-Myers Squibb (BMY) in the absence of transformational data or a de-rating in the shares. Pfizer has high conviction in its current pipeline and believes that the return on investment is considerably higher than high risk transformational deals, particularly in the immuno-oncology space, Baum tells investors in a research note. The analyst expects Pfizer will meaningfully increase its current share repurchase program from the current $5B-$6B per annum to offset the earnings dilution from higher anticipated R&D investment to monetize its current pipeline. Baum keeps a Sell rating on Pfizer and continues to prefer shares of Merck (MRK), Bristol and Eli Lilly (LLY) in the U.S. The analyst lowered his price target for Bristol shares to $70 from $78 with Pfizer backing away from a potential takeover. He keeps a Buy rating on the shares, however.
04/13/18
BMOC
04/13/18
UPGRADE
Target $79
BMOC
Market Perform
Eli Lilly upgraded to Market Perform from Underperform at BMO Capital
BMO Capital analyst Alex Arfaei upgraded Eli Lilly to Market Perform and raised his price target for the shares to $79 from $74.

TODAY'S FREE FLY STORIES

01:45
10/18/18
10/18
01:45
10/18/18
01:45
General news
Asian Market Wrap: »

Asian Market Wrap:…

01:45
10/18/18
10/18
01:45
10/18/18
01:45
General news
Breaking General news story  »

8-Week Bill Settlement to…

23:10
10/17/18
10/17
23:10
10/17/18
23:10
General news
Asia Market Action: equities are mixed »

Asia Market Action:…

PHAS

PhaseBio

$0.00

(0.00%)

21:06
10/17/18
10/17
21:06
10/17/18
21:06
Syndicate
PhaseBio 9.2M share IPO priced at $5.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

MSC

Studio City

$0.00

(0.00%)

21:00
10/17/18
10/17
21:00
10/17/18
21:00
Syndicate
Studio City 28.75M share IPO priced at $12.50 »

The deal was priced at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

BHGE

Baker Hughes

$30.75

-0.09 (-0.29%)

, CJ

C&J Energy Services

$20.40

-0.12 (-0.58%)

20:38
10/17/18
10/17
20:38
10/17/18
20:38
Recommendations
Baker Hughes, C&J Energy Services, FTS International, Halliburton, Keane Group, Nabors Industries, Nine Energy Services, Patterson-UTI, ProPetro Holding, Schlumberger, Covia , Helmerich & Payne, U.S. Silica, Weatherford analyst commentary at BofA/Merrill »

BofA/Merrill reinstating…

BHGE

Baker Hughes

$30.75

-0.09 (-0.29%)

CJ

C&J Energy Services

$20.40

-0.12 (-0.58%)

FTSI

FTS International

$12.87

-0.115 (-0.89%)

HAL

Halliburton

$39.56

-0.52 (-1.30%)

FRAC

Keane Group

$12.50

-0.14 (-1.11%)

NBR

Nabors Industries

$6.25

-0.175 (-2.72%)

NINE

Nine Energy Services

$39.10

0.31 (0.80%)

PTEN

Patterson-UTI

$16.58

-0.37 (-2.18%)

PUMP

ProPetro Holding

$18.19

-0.315 (-1.70%)

SLB

Schlumberger

$59.24

-0.43 (-0.72%)

CVIA

Covia

$7.01

-0.57 (-7.52%)

HP

Helmerich & Payne

$68.06

-1.13 (-1.63%)

SLCA

U.S. Silica

$17.69

-1.03 (-5.50%)

WFT

Weatherford

$2.61

-0.03 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 01

    Nov

  • 01

    Nov

PM

Philip Morris

$84.62

1.12 (1.34%)

, DHR

Danaher

$104.95

-0.13 (-0.12%)

20:25
10/17/18
10/17
20:25
10/17/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PM

Philip Morris

$84.62

1.12 (1.34%)

DHR

Danaher

$104.95

-0.13 (-0.12%)

BK

BNY Mellon

$49.16

-0.17 (-0.34%)

NVS

Novartis

$85.34

-0.41 (-0.48%)

BX

Blackstone

$36.06

-0.02 (-0.06%)

BBT

BB&T

$47.73

0.64 (1.36%)

TRV

Travelers

$126.47

1.75 (1.40%)

PPG

PPG

$98.15

-0.06 (-0.06%)

KEY

KeyCorp

$18.75

0.17 (0.91%)

NUE

Nucor

$59.11

0.17 (0.29%)

TXT

Textron

$64.72

-2.01 (-3.01%)

GPC

Genuine Parts

$95.26

-1.83 (-1.88%)

DOV

Dover

$82.28

-0.95 (-1.14%)

WBC

Wabco

$103.09

-6.91 (-6.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 16

    Nov

  • 13

    Dec

  • 18

    Oct

AVMXY

Avita Medical

$0.00

(0.00%)

19:55
10/17/18
10/17
19:55
10/17/18
19:55
Hot Stocks
Avita Medical announces first U.S. sales of Recell system »

AVITA Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRAC

Keane Group

$12.50

-0.14 (-1.11%)

19:33
10/17/18
10/17
19:33
10/17/18
19:33
Initiation
Keane Group initiated at BofA/Merrill »

Keane Group initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

NBR

Nabors Industries

$6.25

-0.175 (-2.72%)

19:28
10/17/18
10/17
19:28
10/17/18
19:28
Initiation
Nabors Industries initiated at BofA/Merrill »

Nabors Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

NINE

Nine Energy Services

$39.10

0.31 (0.80%)

19:19
10/17/18
10/17
19:19
10/17/18
19:19
Initiation
Nine Energy Services initiated at BofA/Merrill »

Nine Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

PTEN

Patterson-UTI

$16.58

-0.37 (-2.18%)

19:17
10/17/18
10/17
19:17
10/17/18
19:17
Initiation
Patterson-UTI initiated at BofA/Merrill »

Patterson-UTI initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

GSBC

Great Southern Bancorp

$52.51

0.26 (0.50%)

19:04
10/17/18
10/17
19:04
10/17/18
19:04
Earnings
Great Southern Bancorp reports preliminary Q3 EPS $1.18, consensus $1.06 »

Reports Q3 NI $43.0M vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 24

    Oct

HMNY

Helios and Matheson

$0.02

0.001 (5.18%)

18:59
10/17/18
10/17
18:59
10/17/18
18:59
Periodicals
Breaking Periodicals news story on Helios and Matheson »

Helios & Matheson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BY

Byline Bancorp

$21.33

0.02 (0.09%)

18:51
10/17/18
10/17
18:51
10/17/18
18:51
Hot Stocks
Byline Bancorp to acquire Oak Park River Forest Bankshares for $42M »

Byline Bancorp and Oak…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

ABB

ABB

$21.37

-0.115 (-0.54%)

18:48
10/17/18
10/17
18:48
10/17/18
18:48
Periodicals
ABB weighs divesting $10B power grid business, Bloomberg reports »

ABB is working with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VEC

Vectrus

$28.98

-0.74 (-2.49%)

18:22
10/17/18
10/17
18:22
10/17/18
18:22
Hot Stocks
Vectrus names Kevin Boyle chief legal officer »

Vectrus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$6.41

-0.005 (-0.08%)

18:21
10/17/18
10/17
18:21
10/17/18
18:21
Hot Stocks
Sprint extends credits to Florida customers impacted by Hurricane Michael »

Sprint said it continues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

TALO

Talos Energy

$29.85

-1.49 (-4.75%)

18:05
10/17/18
10/17
18:05
10/17/18
18:05
Hot Stocks
Talos Energy reaches pact with Hokchi to cross-assign interests »

Talos Energy Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

STLD

Steel Dynamics

$40.55

0.29 (0.72%)

18:05
10/17/18
10/17
18:05
10/17/18
18:05
Hot Stocks
Steel Dynamics CEO says 'delivered a tremendous third quarter performance' »

"The team delivered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

STLD

Steel Dynamics

$40.55

0.29 (0.72%)

18:02
10/17/18
10/17
18:02
10/17/18
18:02
Hot Stocks
Steel Dynamics CEO: We believe steel consumption will continue to be strong »

"We remain confident…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

STLD

Steel Dynamics

$40.55

0.29 (0.72%)

18:01
10/17/18
10/17
18:01
10/17/18
18:01
Earnings
Steel Dynamics reports Q3 adjusted EPS $1.69, consensus $1.64 »

Reports Q3 revenue $3.2B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

CRTO

Criteo

$23.00

-0.29 (-1.25%)

, RUBI

Rubicon Project

$3.77

-0.06 (-1.57%)

17:44
10/17/18
10/17
17:44
10/17/18
17:44
Periodicals
Advertising technology firm DataXu exploring sale, WSJ says »

DataXu, which offers…

CRTO

Criteo

$23.00

-0.29 (-1.25%)

RUBI

Rubicon Project

$3.77

-0.06 (-1.57%)

FUEL

Rocket Fuel

$0.00

(0.00%)

GOOG

Alphabet

$1,115.99

-4.12 (-0.37%)

FB

Facebook

$159.46

0.65 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

  • 07

    Nov

  • 15

    Nov

  • 16

    Nov

  • 03

    Mar

BTU

Peabody Energy

$36.09

-0.31 (-0.85%)

17:37
10/17/18
10/17
17:37
10/17/18
17:37
Hot Stocks
Peabody Energy increases quarterly dividend nearly 4% to 13c per share »

Peabody Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDN

Brandywine Realty

$14.56

-0.11 (-0.75%)

17:34
10/17/18
10/17
17:34
10/17/18
17:34
Earnings
Brandywine Realty sees FY19 FFO $1.37-$1.47, consensus $1.44 »

Sees FY17 EPS 36c-46c,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.